Riordan, A.M., Hunter, J.O., Cowan, R.E., Crampton, J.R., Davidson, A.R., Dickinson, R.J., Dronfield, M.W., Fellows, I.W., Hishon, S., Kerrigan, G.N., et al. (1993) Treatment of Ac-tive Crohn’s Disease by Exclusion Diet: East Anglian Multicentre Controlled Trial. The Lancet, 342, 1131-1134.
http://dx.doi.org/10.1016/0140-6736(93)92121-9

has been cited by the following article:

• TITLE: Inflammatory Bowel Diseases: What Do We Still Need to Investigate?

  AUTHORS: Marina Taus, Debora Busni, Daniele Fumelli, Arianna Paci, Giulia Nicolai, Albano Nicolai

  KEYWORDS: Inflammatory Bowel Desease, Fecal Mass Transplantation, Nutrition and Macrobiota

  JOURNAL NAME: Open Journal of Gastroenterology, Vol.5 No.10, October 28, 2015

  ABSTRACT: Inflammatory bowel disease (IBD) including Crohn (CD) and ulcerative colitis (UC), is intestinal disorders with an unknown specific etiology. Many factors are involved in the pathogenesis: genetic, environment, nutrition, immunity and intestinal dysbiosis. In the present work, we review the most important trigger mechanisms involved in IBD, with a particular regard to the role of microbiota and fecal mass transplantation as a new therapeutic approach, that even if it can be considered safe and effective, data are necessary regarding all procedures not yet standardized and timing of treatment.